Judith M Bliss

Judith M Bliss

UNVERIFIED PROFILE

Are you Judith M Bliss?   Register this Author

Register author
Judith M Bliss

Judith M Bliss

Publications by authors named "Judith M Bliss"

Are you Judith M Bliss?   Register this Author

60Publications

1600Reads

8Profile Views

Patient advocate involvement in the design and conduct of breast cancer clinical trials requiring the collection of multiple biopsies.

Res Involv Engagem 2018 16;4:22. Epub 2018 Jul 16.

1Division of Clinical Studies, The Institute of Cancer Research Clinical Trials and Statistics Unit, Sir Richard Doll Building, 15 Cotswold Road, Sutton, London, SM2 5NG UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40900-018-0108-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047125PMC
July 2018

Targeted radiotherapy for early breast cancer - Authors' reply.

Lancet 2018 01;391(10115):27-28

Department of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(17)33317-2DOI Listing
January 2018

Conducting non-commercial international clinical trials: the ICR-CTSU experience.

Trials 2017 Sep 26;18(1):440. Epub 2017 Sep 26.

The Institute of Cancer Research Clinical Trials and Statistics Unit, ICR Clinical Trials and Statistics Unit (ICR-CTSU), 15 Cotswold Road, Sutton, Surrey, SM2 5NG, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13063-017-2176-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615436PMC
September 2017

Long-Term Follow-Up of the Intergroup Exemestane Study.

J Clin Oncol 2017 Aug 3;35(22):2507-2514. Epub 2017 May 3.

James P. Morden, Lucy Kilburn, Claire Snowdon, and Judith M. Bliss, The Institute of Cancer Research; Hanna Nicholas, Cancer Research UK; R. Charles Coombes, Imperial College London, London; Gianfilippo Bertelli, Singleton Hospital, Swansea; Robert Coleman, Weston Park Hospital, Sheffield; Lesley Fallowfield, University of Sussex, Brighton; David Dodwell, St James Hospital, Leeds, United Kingdom; Isabel Alvarez, Hospital Donostia, GEICAM Spanish Breast Cancer Group, San Sebastian, Spain; Alan S. Coates, International Breast Cancer Study Group, Bern, Switzerland, and University of Sydney, Sydney, Australia; Jacek Jassem, Medical University of Gdansk, Gdansk, Poland; Stephen Jones, US Oncology Research, The Woodlands, TX; Per E. Lønning, University of Bergen and Haukeland University Hospital, Bergen, Norway; Olaf Ortmann, University Medical Center Regensburg, Regensburg, Germany; Cornelis van de Velde, Leiden University Medical Centre, Leiden, the Netherlands; Jørn Andersen, Aarhus University Hospital, Aarhus, Denmark; Lucia Del Mastro, IRCCS Azienda Ospedaliera Universitaria San Martino IST, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy; Stig Holmberg, Sahlgrenska Universitetssjukhuset, Goteborg, Sweden; and Robert Paridaens, Universitair Ziekenhuis Gasthuisberg, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.5640DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175047PMC
August 2017

Prolongation of overall treatment time as a cause of treatment failure in early breast cancer: An analysis of the UK START (Standardisation of Breast Radiotherapy) trials of radiotherapy fractionation.

Radiother Oncol 2016 12 22;121(3):420-423. Epub 2016 Sep 22.

Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2016.08.027DOI Listing
December 2016

Plasma ESR1 Mutations and the Treatment of Estrogen Receptor-Positive Advanced Breast Cancer.

J Clin Oncol 2016 09 6;34(25):2961-8. Epub 2016 Jun 6.

Charlotte Fribbens, Ben O'Leary, Sarah Hrebien, Isaac Garcia-Murillas, Matthew Beaney, Mitch Dowsett, and Nicholas C. Turner, Institute of Cancer Research; Charlotte Fribbens, Ben O'Leary, Stephen R.D. Johnston, and Nicholas C. Turner, Royal Marsden Hospital; Lucy Kilburn and Judith M. Bliss, The Institute of Cancer Research Clinical Trials and Statistics Unit, London, UK; Massimo Cristofanilli, Thomas Jefferson University, Philadelphia, PA; Fabrice Andre, Institut Gustave Roussy, Villejuif, France; Sherene Loi, University of Melbourne, Melbourne, Australia; Sibylle Loibl, German Breast Group, Neu-Isenburg, Germany; and John Jiang, Cynthia Huang Bartlett, and Maria Koehler, Pfizer, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.3061DOI Listing
September 2016

Reply to S. Kilickap et al, Y. Karakas et al, and I.A. Voutsadakis.

J Clin Oncol 2016 06 21;34(17):2071-2. Epub 2016 Mar 21.

The Institute of Cancer Research, Sutton, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.7709DOI Listing
June 2016

Adjuvant Hormone Therapy May Improve Survival in Epithelial Ovarian Cancer: Results of the AHT Randomized Trial.

J Clin Oncol 2015 Dec 28;33(35):4138-44. Epub 2015 Sep 28.

Rosalind A. Eeles, James P. Morden, and Judith M. Bliss, The Institute of Cancer Research; Martin Gore, The Royal Marsden Hospital; Janine Mansi, St George's Hospital; Peter Harper, Guy's Hospital, London; John Glees, Epsom Hospital, Epsom, and The Royal Marsden Hospital, Sutton; Christopher Williams, Southampton General Hospital, Southampton; Henry Kitchener, Aberdeen Royal Infirmary, Aberdeen; Richard Osborne, Addenbrookes Hospital, Cambridge; David Guthrie, Derbyshire Royal Infirmary, Derby, United Kingdom; and Miklos Wenczl, Markusovszky Teaching Hospital, Szombathely, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.60.9719DOI Listing
December 2015

Hypofractionated radiotherapy in early breast cancer: Clinical, dosimetric and radio-genomic issues.

Breast 2015 Nov 3;24 Suppl 2:S108-13. Epub 2015 Aug 3.

Clinical Trials and Statistic Unit (ICR-CTSU), Division of Clinical Studies, The Institute of Cancer Research & Royal Marsden NHS Foundation Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2015.07.025DOI Listing
November 2015

In Regard to Vaidya et al.

Int J Radiat Oncol Biol Phys 2015 Aug 14;92(5):954-955. Epub 2015 Jul 14.

Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2015.05.026DOI Listing
August 2015

Antiproliferative Effect of Lapatinib in HER2-Positive and HER2-Negative/HER3-High Breast Cancer: Results of the Presurgical Randomized MAPLE Trial (CRUK E/06/039).

Clin Cancer Res 2015 Jul 14;21(13):2932-40. Epub 2014 Nov 14.

The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, United Kingdom. Academic Department of Biochemistry, Royal Marsden NHS Foundation Trust, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-1428DOI Listing
July 2015

The challenges of long-term follow-up data collection in non-commercial, academically-led breast cancer clinical trials: the UK perspective.

Trials 2014 Sep 27;15:379. Epub 2014 Sep 27.

ICR Clinical Trials & Statistics Unit (ICR-CTSU), Division of Clinical Studies, The Institute of Cancer Research, Sir Richard Doll Building, Cotswold Road, London SM2 5NG, UK.

View Article

Download full-text PDF

Source
http://trialsjournal.biomedcentral.com/articles/10.1186/1745
Publisher Site
http://dx.doi.org/10.1186/1745-6215-15-379DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192347PMC
September 2014

Radiotherapy for breast cancer, the TARGIT-A trial.

Lancet 2014 May;383(9930):1716-7

Institute of Cancer Research Clinical Trials and Statistics Unit, Institute of Cancer Research, Sutton, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(14)60826-6DOI Listing
May 2014

Late effects of breast radiotherapy.

Lancet 2014 Apr;383(9926):1383-4

Division of Radiotherapy and Imaging, Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(14)60681-4DOI Listing
April 2014

Phosphorylation of AKT pathway proteins is not predictive of benefit of taxane therapy in early breast cancer.

Breast Cancer Res Treat 2013 Apr 28;138(3):773-81. Epub 2013 Mar 28.

Ontario Institute for Cancer Research, MaRS Centre, South Tower, 101 College Street, Suite 800, Toronto, ON M5G 0A3, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-013-2489-y
Publisher Site
http://dx.doi.org/10.1007/s10549-013-2489-yDOI Listing
April 2013

ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer.

Breast Cancer Res 2012 Mar 14;14(2):R46. Epub 2012 Mar 14.

Academic Department of Biochemistry, The Royal Marsden Hospital, Fulham Road, London, SW3 6JJ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr3145DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446380PMC
March 2012

Ipsilateral breast tumor relapse: local recurrence versus new primary tumor and the effect of whole-breast radiotherapy on the rate of new primaries.

Int J Radiat Oncol Biol Phys 2011 Jan 13;79(1):19-25. Epub 2010 May 13.

Section of Academic Radiotherapy, Royal Marsden Hospital, Sutton, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2009.10.074DOI Listing
January 2011

Reversal of skeletal effects of endocrine treatments in the Intergroup Exemestane Study.

Breast Cancer Res Treat 2010 Nov 21;124(1):153-61. Epub 2010 Aug 21.

Academic Unit of Clinical Oncology, Cancer Research Centre, Weston Park Hospital, Sheffield, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-010-1121-7DOI Listing
November 2010

Intraoperative radiotherapy for early breast cancer.

Lancet 2010 Oct;376(9747):1142; author reply 1143-4

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(10)61531-0DOI Listing
October 2010

The course of anxiety and depression over 5 years of follow-up and risk factors in women with early breast cancer: results from the UK Standardisation of Radiotherapy Trials (START).

Breast 2010 Apr 29;19(2):84-91. Epub 2009 Dec 29.

ICR Clinical Trials and Statistics Unit (ICR-CTSU), Section of Clinical Trials, The Institute of Cancer Research, Sir Richard Doll Building, Cotswold Road, Sutton, Surrey SM2 5NG, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2009.11.007DOI Listing
April 2010

Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials.

Lancet Oncol 2010 Mar 6;11(3):231-40. Epub 2010 Feb 6.

Clinical Trials and Statistics Unit (ICR-CTSU), Section of Clinical Trials, The Institute of Cancer Research, Sutton, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(09)70382-1DOI Listing
March 2010

Influence of psychological response on breast cancer survival: 10-year follow-up of a population-based cohort.

Eur J Cancer 2005 Aug;41(12):1710-4

Department of Psychological Medicine, Royal Marsden Hospital NHS Trust, Downs Road, Sutton SM2 5PT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2005.01.012DOI Listing
August 2005

Safety of exemestane in the Intergroup Exemestane Study.

J Clin Oncol 2005 May;23(13):3171-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.05.361DOI Listing
May 2005

Excision margins in high-risk malignant melanoma.

N Engl J Med 2004 Feb;350(8):757-66

Royal Marsden Hospital National Health Service Trust, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa030681DOI Listing
February 2004

Breast cancer and hormone-replacement therapy: the Million Women Study.

Lancet 2003 Oct;362(9392):1328-9; author reply 1330-1

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(03)14591-6DOI Listing
October 2003